Amarin Corp Plc (AMRN)

[BioChica]

I *think* the NRx/TRx trends in 2020 were showing a change in this behavior, refill rate was climbing,

You have just pointed out what I just said, in this thread. Script renewals should improve with more insurance coverage and lower copay's. It's not the the drug disagrees with there system i.e. side effects. But simply in the past a lot of patients did not have the coverage because of the FDA label issued. So many dropped out because of cost.